Maryann Carousso

Progression‐free and overall survival in patients with relapsed/refractory germ cell tumors treated with single‐agent chemotherapy: Endpoints for clinical trial design

R. Motzer, D. Bajorin, G. Bosl, 2012, Cancer.

Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors

R. Motzer, G. Bosl, M. Ginsberg, 2010, Investigational New Drugs.

Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors.

M. Bains, R. Motzer, D. Bajorin, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT).

M. Bains, R. Motzer, D. Bajorin, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.